Close
Close
Treatment Database
Losartan
Trade Name not avaiable
Orphan Indication Epidermolysis bullosa
EU Market Approval
EU Designation Date 26-02-2019
Sponsor 3R Pharma Consulting GmbH
More about Dystrophic epidermolysis bullosa
Free Newsletter
Related Videos